Industry Research Reports
Home > Reports > Service & Software > Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Service & Software
Published Date: 2026-03-09
Pages: 121 Pages
Report ld: 6037647
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Prenatal Second-Generation DNA Sequencing Market Size(US$)
CAGR 2026-2032
10.9%
Market Size,2032
USD 1,842
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 988 million
Market Forecast in 2032(Value)
US$ 1,842 million
CAGR
10.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 897 million in 2025 and is projected to reach US$ 1842 million, growing at a CAGR of 10.9% from 2026 to 2032.
Prenatal Second-Generation DNA Sequencing refers to prenatal genetic testing that uses second-generation next-generation sequencing methods to generate DNA sequence information relevant to a pregnancy for screening or diagnostic assessment. It typically relies on high-throughput short-read sequencing and computational analysis to detect fetal genetic signals, interpret genomic variation, and produce clinically actionable results that guide follow-up testing and pregnancy management. The approach can be applied through noninvasive workflows that analyze fetal genetic material present in maternal blood as well as through sequencing of fetal or placental samples obtained via clinical procedures, with outputs delivered as structured reports designed to support medical decision making and genetic counseling.
Prenatal Second-Generation DNA Sequencing is becoming a central engine of modernization in prenatal care as health systems seek earlier, safer, and more information-rich assessment of fetal genetic risk. From a research report perspective, market momentum is driven by the scalability of high-throughput sequencing workflows, improving bioinformatics and laboratory automation, and a steady expansion of clinical use cases from core aneuploidy screening toward broader panels and, in selected high-risk pathways, more comprehensive sequencing-based diagnostics. Competitive dynamics are increasingly shaped by analytical performance in low fetal signal conditions, robustness of variant calling and classification, turnaround reliability, integration with clinician-friendly reporting and counseling pathways, and the ability to operate within tightening regulatory and reimbursement expectations. As adoption deepens, differentiation will continue to shift from basic sequencing capacity to end-to-end clinical governance and operational execution, favoring providers that can deliver consistent quality, strong interpretability, and scalable service networks across geographies.
This report provides a comprehensive view of the global market for Prenatal Second-Generation DNA Sequencing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Prenatal Second-Generation DNA Sequencing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Prenatal Second-Generation DNA Sequencing.
MARKET SEGMENTATION
By Company
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- Rainbow Genomics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Weihansi Biomedical Technology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Targeted Panels
- Exome Sequencing
- Others
Segment by Application
- Public Hospitals
- Private Hospitals
Segment by Category
- Non-Invasive
- Invasive
Segment by Division
- Public Health Program
- Consumer
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Prenatal Second-Generation DNA Sequencing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Prenatal Second-Generation DNA Sequencing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Prenatal Second-Generation DNA Sequencing revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Prenatal Second-Generation DNA Sequencing Product Introduction
1.2 Global Prenatal Second-Generation DNA Sequencing Market Size Forecast (2021–2032)
1.3 Prenatal Second-Generation DNA Sequencing Market Trends & Drivers
1.3.1 Prenatal Second-Generation DNA Sequencing Industry Trends
1.3.2 Prenatal Second-Generation DNA Sequencing Market Drivers & Opportunities
1.3.3 Prenatal Second-Generation DNA Sequencing Market Challenges
1.3.4 Prenatal Second-Generation DNA Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prenatal Second-Generation DNA Sequencing Players Revenue Ranking (2025)
2.2 Global Prenatal Second-Generation DNA Sequencing Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Prenatal Second-Generation DNA Sequencing Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Prenatal Second-Generation DNA Sequencing
2.6 Prenatal Second-Generation DNA Sequencing Market Competitive Analysis
2.6.1 Prenatal Second-Generation DNA Sequencing Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Prenatal Second-Generation DNA Sequencing Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prenatal Second-Generation DNA Sequencing revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Prenatal Second-Generation DNA Sequencing Market Classification
3.1 Introduction by Type
3.1.1 Targeted Panels
3.1.2 Exome Sequencing
3.1.3 Others
3.1.4 Global Prenatal Second-Generation DNA Sequencing Sales Value by Type
3.1.4.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Prenatal Second-Generation DNA Sequencing Sales Value, by Type (2021–2032)
3.1.4.3 Global Prenatal Second-Generation DNA Sequencing Sales Value, by Type (%), 2021–2032
3.2 Introduction by Invasiveness
3.2.1 Non-Invasive
3.2.2 Invasive
3.2.3 Global Prenatal Second-Generation DNA Sequencing Sales Value by Invasiveness
3.2.3.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Invasiveness (2021 vs 2025 vs 2032)
3.2.3.2 Global Prenatal Second-Generation DNA Sequencing Sales Value, by Invasiveness (2021–2032)
3.2.3.3 Global Prenatal Second-Generation DNA Sequencing Sales Value, by Invasiveness (%), 2021–2032
3.3 Introduction by Service Model
3.3.1 Public Health Program
3.3.2 Consumer
3.3.3 Others
3.3.4 Global Prenatal Second-Generation DNA Sequencing Sales Value by Service Model
3.3.4.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Service Model (2021 vs 2025 vs 2032)
3.3.4.2 Global Prenatal Second-Generation DNA Sequencing Sales Value, by Service Model (2021–2032)
3.3.4.3 Global Prenatal Second-Generation DNA Sequencing Sales Value, by Service Model (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Public Hospitals
4.1.2 Private Hospitals
4.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application
4.2.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (2021–2032)
4.2.3 Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region
5.1.1 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (2021–2026)
5.1.3 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (2027–2032)
5.1.4 Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
5.2.2 North America Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
5.3.2 Europe Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
5.4.2 Asia Pacific Prenatal Second-Generation DNA Sequencing Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
5.5.2 South America Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
5.6.2 Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prenatal Second-Generation DNA Sequencing Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.3 United States
6.3.1 United States Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.3.2 United States Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.4.2 Europe Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.5.2 China Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.5.3 China Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.6.2 Japan Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.7.2 South Korea Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.8.2 Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Prenatal Second-Generation DNA Sequencing Sales Value, 2021–2032
6.9.2 India Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
6.9.3 India Prenatal Second-Generation DNA Sequencing Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Natera
7.1.1 Natera Profile
7.1.2 Natera Main Business
7.1.3 Natera Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.1.4 Natera Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.1.5 Natera Recent Developments
7.2 Labcorp
7.2.1 Labcorp Profile
7.2.2 Labcorp Main Business
7.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.2.5 Labcorp Recent Developments
7.3 Quest Diagnostics
7.3.1 Quest Diagnostics Profile
7.3.2 Quest Diagnostics Main Business
7.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.3.5 Quest Diagnostics Recent Developments
7.4 MedGenome
7.4.1 MedGenome Profile
7.4.2 MedGenome Main Business
7.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.4.5 MedGenome Recent Developments
7.5 Mayo Clinic Laboratories
7.5.1 Mayo Clinic Laboratories Profile
7.5.2 Mayo Clinic Laboratories Main Business
7.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.5.5 Mayo Clinic Laboratories Recent Developments
7.6 GeneDx
7.6.1 GeneDx Profile
7.6.2 GeneDx Main Business
7.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.6.5 GeneDx Recent Developments
7.7 PreventionGenetics
7.7.1 PreventionGenetics Profile
7.7.2 PreventionGenetics Main Business
7.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.7.5 PreventionGenetics Recent Developments
7.8 SYNLAB
7.8.1 SYNLAB Profile
7.8.2 SYNLAB Main Business
7.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.8.5 SYNLAB Recent Developments
7.9 Myriad Genetics
7.9.1 Myriad Genetics Profile
7.9.2 Myriad Genetics Main Business
7.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.9.5 Myriad Genetics Recent Developments
7.10 GGA
7.10.1 GGA Profile
7.10.2 GGA Main Business
7.10.3 GGA Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.10.4 GGA Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.10.5 GGA Recent Developments
7.11 Fulgent Genetics
7.11.1 Fulgent Genetics Profile
7.11.2 Fulgent Genetics Main Business
7.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.11.5 Fulgent Genetics Recent Developments
7.12 Rainbow Genomics
7.12.1 Rainbow Genomics Profile
7.12.2 Rainbow Genomics Main Business
7.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.12.5 Rainbow Genomics Recent Developments
7.13 BillionToOne
7.13.1 BillionToOne Profile
7.13.2 BillionToOne Main Business
7.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.13.5 BillionToOne Recent Developments
7.14 BGI Genomics
7.14.1 BGI Genomics Profile
7.14.2 BGI Genomics Main Business
7.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.14.5 BGI Genomics Recent Developments
7.15 Berry Genomics
7.15.1 Berry Genomics Profile
7.15.2 Berry Genomics Main Business
7.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.15.5 Berry Genomics Recent Developments
7.16 Annaroad
7.16.1 Annaroad Profile
7.16.2 Annaroad Main Business
7.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.16.5 Annaroad Recent Developments
7.17 Weihansi Biomedical Technology
7.17.1 Weihansi Biomedical Technology Profile
7.17.2 Weihansi Biomedical Technology Main Business
7.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
7.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), 2021–2026
7.17.5 Weihansi Biomedical Technology Recent Developments
8 Industry Chain Analysis
8.1 Prenatal Second-Generation DNA Sequencing Value Chain
8.2 Prenatal Second-Generation DNA Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Prenatal Second-Generation DNA Sequencing Sales Model
8.5.2 Sales Channels
8.5.3 Prenatal Second-Generation DNA Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Prenatal Second-Generation DNA Sequencing Market Trends
Table 2. Prenatal Second-Generation DNA Sequencing Market Drivers & Opportunities
Table 3. Prenatal Second-Generation DNA Sequencing Market Challenges
Table 4. Prenatal Second-Generation DNA Sequencing Market Restraints
Table 5. Global Prenatal Second-Generation DNA Sequencing Revenue by Company (US$ Million), 2021–2026
Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Prenatal Second-Generation DNA Sequencing Product Type
Table 9. Key Companies General Availability (GA) Timeline for Prenatal Second-Generation DNA Sequencing
Table 10. Global Prenatal Second-Generation DNA Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prenatal Second-Generation DNA Sequencing revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Type (2021–2026)
Table 17. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Type (2027–2032)
Table 18. Global Prenatal Second-Generation DNA Sequencing Sales Value by Invasiveness: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Prenatal Second-Generation DNA Sequencing Sales Value by Invasiveness (US$ Million), 2021–2026
Table 20. Global Prenatal Second-Generation DNA Sequencing Sales Value by Invasiveness (US$ Million), 2027–2032
Table 21. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Invasiveness (2021–2026)
Table 22. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Invasiveness (2027–2032)
Table 23. Global Prenatal Second-Generation DNA Sequencing Sales Value by Service Model: 2021 vs 2025 vs 2032 (US$ Million)
Table 24. Global Prenatal Second-Generation DNA Sequencing Sales Value by Service Model (US$ Million), 2021–2026
Table 25. Global Prenatal Second-Generation DNA Sequencing Sales Value by Service Model (US$ Million), 2027–2032
Table 26. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Service Model (2021–2026)
Table 27. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Service Model (2027–2032)
Table 28. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Application (2021–2026)
Table 32. Global Prenatal Second-Generation DNA Sequencing Sales Market Share in Value by Application (2027–2032)
Table 33. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 34. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (US$ Million), 2021–2026
Table 35. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (US$ Million), 2027–2032
Table 36. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (%), 2021–2026
Table 37. Global Prenatal Second-Generation DNA Sequencing Sales Value by Region (%), 2027–2032
Table 38. Key Countries/Regions Prenatal Second-Generation DNA Sequencing Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 39. Key Countries/Regions Prenatal Second-Generation DNA Sequencing Sales Value, (US$ Million), 2021–2026
Table 40. Key Countries/Regions Prenatal Second-Generation DNA Sequencing Sales Value, (US$ Million), 2027–2032
Table 41. Natera Basic Information List
Table 42. Natera Description and Business Overview
Table 43. Natera Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Natera (2021–2026)
Table 45. Natera Recent Developments
Table 46. Labcorp Basic Information List
Table 47. Labcorp Description and Business Overview
Table 48. Labcorp Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Labcorp (2021–2026)
Table 50. Labcorp Recent Developments
Table 51. Quest Diagnostics Basic Information List
Table 52. Quest Diagnostics Description and Business Overview
Table 53. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Quest Diagnostics (2021–2026)
Table 55. Quest Diagnostics Recent Developments
Table 56. MedGenome Basic Information List
Table 57. MedGenome Description and Business Overview
Table 58. MedGenome Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of MedGenome (2021–2026)
Table 60. MedGenome Recent Developments
Table 61. Mayo Clinic Laboratories Basic Information List
Table 62. Mayo Clinic Laboratories Description and Business Overview
Table 63. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Mayo Clinic Laboratories (2021–2026)
Table 65. Mayo Clinic Laboratories Recent Developments
Table 66. GeneDx Basic Information List
Table 67. GeneDx Description and Business Overview
Table 68. GeneDx Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of GeneDx (2021–2026)
Table 70. GeneDx Recent Developments
Table 71. PreventionGenetics Basic Information List
Table 72. PreventionGenetics Description and Business Overview
Table 73. PreventionGenetics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of PreventionGenetics (2021–2026)
Table 75. PreventionGenetics Recent Developments
Table 76. SYNLAB Basic Information List
Table 77. SYNLAB Description and Business Overview
Table 78. SYNLAB Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of SYNLAB (2021–2026)
Table 80. SYNLAB Recent Developments
Table 81. Myriad Genetics Basic Information List
Table 82. Myriad Genetics Description and Business Overview
Table 83. Myriad Genetics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Myriad Genetics (2021–2026)
Table 85. Myriad Genetics Recent Developments
Table 86. GGA Basic Information List
Table 87. GGA Description and Business Overview
Table 88. GGA Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of GGA (2021–2026)
Table 90. GGA Recent Developments
Table 91. Fulgent Genetics Basic Information List
Table 92. Fulgent Genetics Description and Business Overview
Table 93. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Fulgent Genetics (2021–2026)
Table 95. Fulgent Genetics Recent Developments
Table 96. Rainbow Genomics Basic Information List
Table 97. Rainbow Genomics Description and Business Overview
Table 98. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Rainbow Genomics (2021–2026)
Table 100. Rainbow Genomics Recent Developments
Table 101. BillionToOne Basic Information List
Table 102. BillionToOne Description and Business Overview
Table 103. BillionToOne Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 104. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of BillionToOne (2021–2026)
Table 105. BillionToOne Recent Developments
Table 106. BGI Genomics Basic Information List
Table 107. BGI Genomics Description and Business Overview
Table 108. BGI Genomics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 109. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of BGI Genomics (2021–2026)
Table 110. BGI Genomics Recent Developments
Table 111. Berry Genomics Basic Information List
Table 112. Berry Genomics Description and Business Overview
Table 113. Berry Genomics Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 114. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Berry Genomics (2021–2026)
Table 115. Berry Genomics Recent Developments
Table 116. Annaroad Basic Information List
Table 117. Annaroad Description and Business Overview
Table 118. Annaroad Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 119. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Annaroad (2021–2026)
Table 120. Annaroad Recent Developments
Table 121. Weihansi Biomedical Technology Basic Information List
Table 122. Weihansi Biomedical Technology Description and Business Overview
Table 123. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Products, Services, and Solutions
Table 124. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Weihansi Biomedical Technology (2021–2026)
Table 125. Weihansi Biomedical Technology Recent Developments
Table 126. Revenue (US$ Million) in Prenatal Second-Generation DNA Sequencing Business of Company 40 (2021–2026)
Table 127. Company 40 Recent Developments
Table 128. Key Raw Materials Lists
Table 129. Key Suppliers of Raw Materials Lists
Table 130. Prenatal Second-Generation DNA Sequencing Downstream Customers
Table 131. Prenatal Second-Generation DNA Sequencing Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Prenatal Second-Generation DNA Sequencing Product Picture
Figure 2. Global Prenatal Second-Generation DNA Sequencing Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 4. Prenatal Second-Generation DNA Sequencing Report Years Considered
Figure 5. Global Prenatal Second-Generation DNA Sequencing Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Prenatal Second-Generation DNA Sequencing Revenue in 2025
Figure 7. Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Targeted Panels Picture
Figure 9. Exome Sequencing Picture
Figure 10. Others Picture
Figure 11. Global Prenatal Second-Generation DNA Sequencing Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Prenatal Second-Generation DNA Sequencing Sales Value Market Share by Type, 2025 & 2032
Figure 13. Non-Invasive Picture
Figure 14. Invasive Picture
Figure 15. Global Prenatal Second-Generation DNA Sequencing Sales Value by Invasiveness (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Prenatal Second-Generation DNA Sequencing Sales Value Market Share by Invasiveness, 2025 & 2032
Figure 17. Public Health Program Picture
Figure 18. Consumer Picture
Figure 19. Others Picture
Figure 20. Global Prenatal Second-Generation DNA Sequencing Sales Value by Service Model (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Prenatal Second-Generation DNA Sequencing Sales Value Market Share by Service Model, 2025 & 2032
Figure 22. Product Picture of Public Hospitals
Figure 23. Product Picture of Private Hospitals
Figure 24. Global Prenatal Second-Generation DNA Sequencing Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Prenatal Second-Generation DNA Sequencing Sales Value Market Share by Application, 2025 & 2032
Figure 26. North America Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 27. North America Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 29. Europe Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Prenatal Second-Generation DNA Sequencing Sales Value by Subregion (%), 2025 vs 2032
Figure 32. South America Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 33. South America Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Prenatal Second-Generation DNA Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Prenatal Second-Generation DNA Sequencing Sales Value (%), 2021–2032
Figure 37. United States Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 38. United States Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 39. United States Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 40. Europe Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 41. Europe Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 42. Europe Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 43. China Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 44. China Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 45. China Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 46. Japan Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 47. Japan Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 48. Japan Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 49. South Korea Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 50. South Korea Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 51. South Korea Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 52. Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 53. Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 54. Southeast Asia Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 55. India Prenatal Second-Generation DNA Sequencing Sales Value (US$ Million), 2021–2032
Figure 56. India Prenatal Second-Generation DNA Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 57. India Prenatal Second-Generation DNA Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 58. Prenatal Second-Generation DNA Sequencing Value Chain
Figure 59. Prenatal Second-Generation DNA Sequencing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Prenatal Second-Generation DNA Sequencing in 2032?
The global market size of Prenatal Second-Generation DNA Sequencing in 2032 was 1842 Million USD.
What was the global market size of Prenatal Second-Generation DNA Sequencing in 2026?
What is the annual compound growth rate of the global Prenatal Second-Generation DNA Sequencing market size from 2026 to 2032?
Which companies rank high in the global Prenatal Second-Generation DNA Sequencing market?
Which region is expected to have the highest market share?
Related Reports
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026
The global Prenatal Second-Generation DNA Sequencing market was valued at US$ 897 million in 2025 and is anticipated to reach US$ 1842 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 130
USD 2900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 897 million in 2025 to US$ 1842 million by 2032, at a CAGR of 10.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 151
USD 4900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Prenatal Second-Generation DNA Sequencing market size was US$ 897 million in 2025 and is forecast to reach a readjusted size of US$ 1842 million by 2032 with a CAGR of 10.9% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 106
USD 4250.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-04-13
Pages: 108
USD 2900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prenatal Second-Generation DNA Sequencing market size was US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 117
USD 4250.00
(Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 160
USD 3950.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Insights, Forecast to 2031
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 1414 million in 2025 to US$ 2458 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Published Date: 2025-04-13
Pages: 166
USD 4900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026
The global Prenatal Second-Generation DNA Sequencing market was valued at US$ 897 million in 2025 and is anticipated to reach US$ 1842 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 130
USD 2900.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 897 million in 2025 to US$ 1842 million by 2032, at a CAGR of 10.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 151
USD 4900.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Prenatal Second-Generation DNA Sequencing market size was US$ 897 million in 2025 and is forecast to reach a readjusted size of US$ 1842 million by 2032 with a CAGR of 10.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 106
USD 4250.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-04-13
Pages: 108
USD 2900.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prenatal Second-Generation DNA Sequencing market size was US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 117
USD 4250.00 (Single User License)Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 160
USD 3950.00 (Single User License)Global Prenatal Second-Generation DNA Sequencing Market Insights, Forecast to 2031
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 1414 million in 2025 to US$ 2458 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Published: 2025-04-13
Pages: 166
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now